IKK-2 inhibitor TPCA-1 represses nasal epithelial inflammation in vitro

Frank B. Sachse(C3J Therapeutics (United States)), Claudia Rudack(Klinik und Poliklinik für Hals-, Nasen-, Ohrenheilkunde)
Rhinology Journal
June 1, 2011
Cited by 21


Related Papers